Yilei Mao
Welcome,         Profile    Billing    Logout  
 5 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mao, Yilei
NCT05161143: Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma

Not yet recruiting
2
30
RoW
Donafenib, TACE
Peking Union Medical College Hospital, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Hepatocellular Carcinoma
12/23
12/24
NCT04755907: 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases

Recruiting
N/A
120
RoW
surgical resection, adjuvant chemotherapy, neoadjuvant therapy
Peking Union Medical College Hospital, Beijing Cancer Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, China-Japan Friendship Hospital
Colorectal Cancer, Colorectal Cancer Liver Metastasis
12/22
12/23
NCT05955092: Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma

Recruiting
N/A
30
RoW
Peking Union Medical College Hospital
Pancreatic Ductal Adenocarcinoma
06/24
09/24

Download Options